drugset / Trial / NCT02070159

Prasugrel With Lower Dose - Loading Dose

NCT02070159

Phase 3 Completed 43 enrolled Dong-A University
RandomizedParallel-groupOpen-labelTreatment

Summary

Although prasugrel, recently available thienopyridine derivative, exhibits rapid and potent platelet inhibition, concerns of low on-treatment platelet reactivity have been suggested especially in East Asian ethnicities. The investigators compared the effect of lower loading dose of prasugrel with conventional loading dose of clopidogrel and prasugrel.

Timeline

Start
2011-12
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 600 mg
Comparator Prasugrel Small molecule 30 mg
Comparator Prasugrel Small molecule 60 mg